is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Medical diagnostic testing at or near the point of care—that is, at the time and place of patient care is the new trending topic in the field of medical laboratory. State-of-the-art molecular point-of-care testing for disease detection empowers physicians with the ability to make early evidence-based treatment decisions. With insights by leading industry analysts, let's look at how advance molecular point-of-care testing in the Asia Pacific region has helped improve disease detection and patient outcome.